Ligand validation:7ZN3

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ZN3_LFA_A_519	39%	96%	0.09	0.885	0.19	0.16	-	-	0	0	50%	0.5
7ZN3_LFA_B_304	39%	96%	0.085	0.907	0.11	0.26	-	-	1	0	35%	0.35
7ZN3_LFA_A_501	36%	99%	0.086	0.904	0.13	0.1	-	-	1	0	30%	0.3
7ZN3_LFA_C_309	33%	89%	0.08	0.902	0.17	0.46	-	-	0	0	20%	0.2
7ZN3_LFA_C_311	29%	99%	0.103	0.86	0.13	0.09	-	-	0	0	45%	0.45
7ZN3_LFA_A_512	29%	91%	0.1	0.873	0.29	0.3	-	-	1	0	35%	0.35
7ZN3_LFA_B_312	28%	94%	0.106	0.855	0.18	0.26	-	-	1	0	45%	0.45
7ZN3_LFA_B_318	28%	97%	0.14	0.834	0.21	0.11	-	-	0	0	75%	0.75
7ZN3_LFA_C_312	27%	99%	0.101	0.854	0.14	0.1	-	-	0	0	40%	0.4
7ZN3_LFA_C_301	27%	95%	0.207	0.879	0.17	0.23	-	-	0	0	85%	0.85
7ZN3_LFA_B_311	27%	98%	0.115	0.856	0.12	0.13	-	-	1	0	45%	0.45
7ZN3_LFA_A_502	26%	99%	0.165	0.904	0.1	0.14	-	-	0	0	45%	0.45
7ZN3_LFA_B_314	24%	89%	0.096	0.858	0.25	0.39	-	-	0	0	25%	0.25
7ZN3_LFA_C_318	23%	96%	0.13	0.884	0.12	0.22	-	-	0	0	25%	0.25
7ZN3_LFA_B_303	19%	95%	0.226	0.924	0.15	0.25	-	-	0	0	45%	0.45
7ZN3_LFA_B_320	19%	100%	0.157	0.801	0.11	0.07	-	-	0	0	70%	0.7
7ZN3_LFA_A_511	18%	97%	0.13	0.812	0.13	0.17	-	-	0	0	45%	0.45
7ZN3_LFA_B_302	17%	94%	0.213	0.834	0.26	0.18	-	-	0	0	75%	0.75
7ZN3_LFA_C_307	16%	98%	0.155	0.81	0.17	0.1	-	-	2	0	50%	0.5
7ZN3_LFA_A_513	15%	98%	0.15	0.779	0.15	0.12	-	-	0	0	60%	0.6
7ZN3_LFA_C_314	14%	99%	0.154	0.805	0.11	0.1	-	-	0	0	45%	0.45
7ZN3_LFA_A_518	14%	95%	0.159	0.846	0.27	0.14	-	-	3	0	25%	0.25
7ZN3_LFA_B_313	14%	93%	0.105	0.772	0.22	0.25	-	-	0	0	35%	0.35
7ZN3_LFA_B_315	14%	94%	0.184	0.867	0.16	0.29	-	-	0	0	25%	0.25
7ZN3_LFA_B_319	14%	99%	0.153	0.796	0.11	0.09	-	-	1	0	45%	0.45
7ZN3_LFA_C_316	13%	100%	0.167	0.791	0.1	0.08	-	-	1	0	55%	0.55
7ZN3_LFA_C_315	13%	100%	0.126	0.766	0.11	0.06	-	-	3	0	45%	0.45
7ZN3_LFA_C_319	12%	100%	0.154	0.785	0.11	0.08	-	-	1	0	40%	0.4
7ZN3_LFA_C_310	10%	97%	0.159	0.77	0.13	0.19	-	-	0	0	40%	0.4
7ZN3_LFA_A_516	10%	97%	0.17	0.797	0.22	0.12	-	-	1	0	30%	0.3
7ZN3_LFA_B_317	10%	85%	0.153	0.794	0.31	0.43	-	-	0	0	20%	0.2
7ZN3_LFA_B_301	9%	90%	0.228	0.833	0.23	0.38	-	-	1	0	35%	0.35
7ZN3_LFA_A_514	8%	99%	0.189	0.78	0.14	0.1	-	-	0	0	35%	0.35
7ZN3_LFA_A_503	7%	91%	0.283	0.865	0.22	0.34	-	-	0	0	35%	0.35
7ZN3_LFA_C_313	7%	95%	0.316	0.883	0.18	0.23	-	-	2	0	40%	0.4
7ZN3_LFA_B_321	7%	100%	0.25	0.796	0.11	0.08	-	-	0	0	50%	0.5
7ZN3_LFA_A_510	7%	99%	0.25	0.795	0.12	0.08	-	-	0	0	45%	0.45
7ZN3_LFA_C_317	7%	99%	0.192	0.735	0.12	0.1	-	-	1	0	45%	0.45
7ZN3_LFA_A_520	6%	100%	0.178	0.709	0.11	0.05	-	-	1	0	50%	0.5
7ZN3_LFA_A_515	6%	96%	0.252	0.793	0.16	0.21	-	-	0	0	40%	0.4
7ZN3_LFA_B_316	4%	96%	0.235	0.734	0.18	0.18	-	-	0	0	30%	0.3
7ZN3_LFA_B_310	4%	99%	0.15	0.641	0.12	0.09	-	-	0	0	30%	0.3
7ZN3_LFA_C_308	3%	95%	0.263	0.617	0.21	0.18	-	-	0	0	80%	0.8
7ZNA_LFA_B_317	42%	100%	0.105	0.914	0.08	0.09	-	-	0	0	50%	0.5
7ZMY_LFA_B_319	39%	98%	0.101	0.897	0.13	0.15	-	-	3	0	50%	0.5
7ZN8_LFA_A_719	38%	100%	0.125	0.89	0.09	0.07	-	-	1	0	65%	0.65
7ZN0_LFA_B_322	36%	100%	0.107	0.869	0.09	0.06	-	-	3	0	60%	0.6
7ZNE_LFA_B_302	34%	99%	0.096	0.892	0.1	0.13	-	-	0	0	35%	0.35
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.